Moringa is an expeditious-growing evergreen perennial plant and has wide adaptability to grow in different environmental conditions. The nutritive value and medicinal benefits of its leaves, flowers, pods, roots, and stem barks are established by philanthropic research. Edible parts are rich in protein, vitamins, minerals, antioxidants, and other chemical compounds with medicinal properties. The pods and leaves are mainly used as vegetables and ingredients in soups and curries. It is used to boost the nutritional value of food, as well as to boost the immune system and antioxidant levels, lower blood sugar levels and maintain inflammation. Moreover, Moringa leaves flavonoid amelioration of total antioxidant capacity in the lens. Its leaves, pods, and leaf powder contain a high proportion of Vitamin A, which can help to prevent night blindness and eye problems in children.

Background: According to study, Retinal vein occlusion (RVO) is the second most common retinal vasculopathy after diabetic retinopathy, which causes permanent visual loss. Objective: In this study our main goal is to assess the association between retinal vein occlusion and axial length of eyeball. Method: This cross sectional study was carried out at Department of Ophthalmology, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka from From March 2016 to March 2019. Where 60 Patients who were attending in the Department of Ophthalmology, BSMMU was the population of the study. During the study, 30 patients with retinal vein occlusion are included in Group A whereas remaining patients with no refractive error and no RVO are included in Group B. Results: During the study, in both group majority of the cases belong to 41-50 years age group whereas 17(56.7%) patients were male in group A and 12(40.0%) in group B. Fourteen (43.3%) patients were female in group A and 18(60.0%) in group B.In group A, 17(56.7%) patients were affected in left eye, 11(36.7%) in right eye and 2(6.7%) in bilateral eyes. Eighteen (60.0%) patients were found affected with BRVO and 12(40.0%) with CRVO. Whereas Mean axial length of eyeball was found 22.81±0.67 mm in affected eyes of group A and 23.38±0.92 mm in eyes of group B. The mean axial length of eyeball was found 22.82±0.78 mm in fellow eyes of group A and 23.38±0.92 mm in eyes of group B. Besides that, mean axial length of eyeball was found 22.69±0.54 mm in affected eyes of BRVO and 23.38±0.92 mm in eyes of group B. The mean axial length of eyeball was found 22.70±0.71 mm in fellow eyes of BRVO and 23.38±0.92 mm in eyes of group B. The differences were statistically significant (p<0.05). Conclusion: On the basis of the findings in this study, it may be surmised that shorter axial length may be a local risk factor for developing RVO.